We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unlocking Q2 Potential of Intuitive Surgical (ISRG): Exploring Wall Street Estimates for Key Metrics
Read MoreHide Full Article
In its upcoming report, Intuitive Surgical, Inc. (ISRG - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.92 per share, reflecting an increase of 7.9% compared to the same period last year. Revenues are forecasted to be $2.35 billion, representing a year-over-year increase of 16.8%.
The consensus EPS estimate for the quarter has undergone an upward revision of 0.1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Given this perspective, it's time to examine the average forecasts of specific Intuitive Surgical metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts forecast 'Revenue- Product (Instruments and accessories and Systems)' to reach $1.96 billion. The estimate points to a change of +15.7% from the year-ago quarter.
The consensus estimate for 'Revenue- Services' stands at $368.86 million. The estimate suggests a change of +16.3% year over year.
The combined assessment of analysts suggests that 'Revenue- Systems' will likely reach $516.21 million. The estimate indicates a year-over-year change of +15.2%.
The average prediction of analysts places 'Revenue- Instruments and accessories' at $1.44 billion. The estimate indicates a change of +15.9% from the prior-year quarter.
Based on the collective assessment of analysts, 'Total System Units Placed - Total Company' should arrive at 395 . Compared to the current estimate, the company reported 341 in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Total Number of Procedures' of 771,122 . The estimate compares to the year-ago value of 661,000 .
According to the collective judgment of analysts, 'Da Vinci Surgical System Installed Base' should come in at 10,427 . The estimate compares to the year-ago value of 9,203 .
It is projected by analysts that the 'Total System Units Placed - Outside of the United States' will reach 184 . The estimate is in contrast to the year-ago figure of 192 .
Analysts expect 'Total System Units Placed - United States' to come in at 211 . Compared to the present estimate, the company reported 149 in the same quarter last year.
The consensus among analysts is that 'Gross profit- Service' will reach $245.26 million. Compared to the current estimate, the company reported $219.50 million in the same quarter of the previous year.
Over the past month, shares of Intuitive Surgical have returned +0.6% versus the Zacks S&P 500 composite's +4.2% change. Currently, ISRG carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unlocking Q2 Potential of Intuitive Surgical (ISRG): Exploring Wall Street Estimates for Key Metrics
In its upcoming report, Intuitive Surgical, Inc. (ISRG - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.92 per share, reflecting an increase of 7.9% compared to the same period last year. Revenues are forecasted to be $2.35 billion, representing a year-over-year increase of 16.8%.
The consensus EPS estimate for the quarter has undergone an upward revision of 0.1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Given this perspective, it's time to examine the average forecasts of specific Intuitive Surgical metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts forecast 'Revenue- Product (Instruments and accessories and Systems)' to reach $1.96 billion. The estimate points to a change of +15.7% from the year-ago quarter.
The consensus estimate for 'Revenue- Services' stands at $368.86 million. The estimate suggests a change of +16.3% year over year.
The combined assessment of analysts suggests that 'Revenue- Systems' will likely reach $516.21 million. The estimate indicates a year-over-year change of +15.2%.
The average prediction of analysts places 'Revenue- Instruments and accessories' at $1.44 billion. The estimate indicates a change of +15.9% from the prior-year quarter.
Based on the collective assessment of analysts, 'Total System Units Placed - Total Company' should arrive at 395 . Compared to the current estimate, the company reported 341 in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Total Number of Procedures' of 771,122 . The estimate compares to the year-ago value of 661,000 .
According to the collective judgment of analysts, 'Da Vinci Surgical System Installed Base' should come in at 10,427 . The estimate compares to the year-ago value of 9,203 .
It is projected by analysts that the 'Total System Units Placed - Outside of the United States' will reach 184 . The estimate is in contrast to the year-ago figure of 192 .
Analysts expect 'Total System Units Placed - United States' to come in at 211 . Compared to the present estimate, the company reported 149 in the same quarter last year.
The consensus among analysts is that 'Gross profit- Service' will reach $245.26 million. Compared to the current estimate, the company reported $219.50 million in the same quarter of the previous year.
Analysts' assessment points toward 'Cost of revenue- Service' reaching $118.34 million.
View all Key Company Metrics for Intuitive Surgical here>>>Over the past month, shares of Intuitive Surgical have returned +0.6% versus the Zacks S&P 500 composite's +4.2% change. Currently, ISRG carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .